This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Nanexa AB (publ)
Q42024
2/18/2025
Host
Moderator
Welcome to this report interview and final communication interview with the drug delivery company Nanexa in the fourth quarter. With us from the company is CEO Göran Ando and CEO David Westberg. Today we will start with a presentation of Göran Ando's GLP-1 overview before we let David in to comment on the quarter and they are both here in the studio. You who are watching can ask questions via live chat. Ladies and gentlemen, welcome. Thank you. It's great to have you here again. David, how happy are you with the report?
David Westberg
CEO
I am very happy. I am very happy with the conclusion of last year when we got the study results from our NEXU 2 project. Very happy.
Host
Moderator
And Göran, you will give us an insight into the wonderful world of GLP-1s.
You're reading a preview of the NANEXA.ST Q4 2024 earnings call.
Free account.
Disclaimer